CELIN CARABALLO: Open Payments
NPI 1134851520 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,778 in 89 payments from 25 companies in 2025. Trend: 2023 $1,947 · 2024 $1,870 · 2025 $1,778
Food & beverage: $1,778
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $419 |
| Teva Pharmaceuticals USA, Inc. | 12 | $199 |
| SCPHARMACEUTICALS INC. | 9 | $161 |
| Lundbeck LLC | 5 | $113 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Alkermes, Inc. | 3 | $74 |
| Aimmune Therapeutics, Inc. | 4 | $70 |
| Amgen Inc. | 4 | $66 |
| ABBVIE INC. | 3 | $62 |
| Lilly USA, LLC | 3 | $61 |
Products named: AIRSUPRA, REXULTI, FUROSCIX, AUSTEDO XR, UZEDY, FARXIGA, ARISTADA, ZENPEP.
Industry payments across OH — which companies pay providers there.
